American Capital Advisory’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.2K Hold
155
– – ﹤0.01% 357
2026
Q2
$11K Sell
155
-1
-0.6% -$54 ﹤0.01% 353
2026
Q1
$8.15K Buy
156
+9
+6% +$540 ﹤0.01% 358
2025
Q4
$8.65K Hold
147
– – ﹤0.01% 337
2025
Q3
$8.18K Hold
147
– – ﹤0.01% 323
2025
Q2
$7.56K Buy
+147
New +$7.39K ﹤0.01% 310

Other funds holding TECH

American Capital Advisory's TECH Position: Q3 2026 in Review

American Capital Advisory held its Bio-Techne (TECH) position steady in Q3 2026 at 155 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #357.

American Capital Advisory first reported a position in TECH in Q2 2025 and has held it in 6 quarters since. 586 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • American Capital Advisory held 155 shares of Bio-Techne worth $11.2K as of Q3 2026.
  • American Capital Advisory left its Bio-Techne share count unchanged in Q3 2026.
  • Bio-Techne made up ﹤0.01% of American Capital Advisory's portfolio in Q3 2026, its #357 holding.
  • American Capital Advisory first reported a position in Bio-Techne in Q2 2025 and has held it in 6 quarters since.
  • 586 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on American Capital Advisory's 13F filing for Q3 2026, filed 28 Oct 2026.